Uniper SE
LSE:0RJ4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Uniper SE
LSE:0RJ4
|
DE |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
Wall St Price Targets
0RJ4 Price Targets Summary
Uniper SE
According to Wall Street analysts, the average 1-year price target for 0RJ4 is 35.537 EUR with a low forecast of 32.957 EUR and a high forecast of 41.115 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RJ4's stock price target?
Price Target
35.537
EUR
According to Wall Street analysts, the average 1-year price target for 0RJ4 is 35.537 EUR with a low forecast of 32.957 EUR and a high forecast of 41.115 EUR.
What is the Revenue forecast for Uniper SE?
Projected CAGR
2%
Over the last 4 years, the compound annual growth rate for Revenue has been -22%. The projected CAGR for the next 3 years is 2%.
What is the Operating Income forecast for Uniper SE?
Projected CAGR
3%
Over the last 4 years, the compound annual growth rate for Operating Income has been -35%. The projected CAGR for the next 3 years is 3%.
What is the Net Income forecast for Uniper SE?
Projected CAGR
-23%
The compound annual growth rate for Net Income over the next 3 years is -23%.
